H.I.G. BioHealth Partners is the dedicated life-science investment affiliate of H.I.G. Capital, investing in a broad range of healthcare companies across sectors and stages of development, including therapeutic drugs, medical devices, diagnostics, and digital health.
Average disclosed round size is $40.6M (across 4 rounds with reported amounts).
Portfolio
5
Fund Size
$400M
Top Stage
Unknown
Last 12 Mo
0
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
5 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| OOn Target Laboratories | Series C | $30M | Nov 2023 |
 Click Therapeutics | Series B | $48.5M | Jan 2021 |
 On Target Labs | Series B | $44M | Mar 2018 |
| VVertiflex, Inc. | Unknown | $40M | Jan 2017 |
| AArvelle Therapeutics | Unknown | — | — |
Top Co-Investors
Elevate Ventures2 shared
Andera Partners1 shared
EQT Life Sciences1 shared
NovaQuest Capital Management1 shared
BRV Capital Management1 shared
Sanofi Ventures1 shared
Accelmed Partners1 shared
3B Future Health Fund1 shared
Olympus Innovation Ventures1 shared
New Enterprise Associates1 shared
Morgenthaler Ventures1 shared
Alta Partners1 shared
Endeavour Vision1 shared
Last updated: 8 September 2026